Wednesday, June 1, 2011

New Drug Approved for Clostridium Diarrhoea

Clostridium difficile infection usually acquired from hospital or occurs as a super infection following long term antibiotic administration.
 Micrograph of a colonic pseudomembrane in pseu...Image via Wikipedia
Amplify’d from www.fda.gov
FDA approves treatment for Clostridium difficile infection
The U.S. Food and Drug Administration today approved Dificid (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD).
Clostridium difficile (C. difficile) is a bacterium that can cause diarrhea and lead to colitis, other serious intestinal conditions, and death in severe cases. C. difficile bacteria are found in the stool of an infected person, and others can become infected if they touch items or surfaces contaminated with the bacteria or spores and then touch their mouths.
Read more at www.fda.gov

Enhanced by Zemanta

No comments:

Post a Comment

Please React.

Featured Post

Cyclodextrin for Treatment of Atherosclerosis

Cardiovascular disease from atherosclerosis is one of the most common causes of death worldwide. Inflammation plays a crucial role in ...